A generic crystallopathic model for chronic kidney disease progression.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
16 08 2021
Historique:
entrez: 16 8 2021
pubmed: 17 8 2021
medline: 30 10 2021
Statut: ppublish

Résumé

Chronic kidney disease (CKD) has reached epidemic proportions globally. The natural course of chronic kidney disease is almost uniformly progressive, albeit at different rates in different individuals. The downhill course appears to pervade kidney diseases of all etiologies and seems to spiral down a self-perpetuating vortex, even if the original insult is ameliorated or controlled. In this issue of the JCI, Shiizaki, Tsubouchi, and colleagues proposed a model of renal tubule luminal calcium phosphate crystallopathy that accounts for renal function demise. Calcium phosphate crystals attached to TLR4 and underwent endocytosis at the brush border, triggering inflammation and fibrosis. This mechanism might operate in different kinds of kidney disease, with a theoretical phosphate concentration threshold in the proximal tubular lumen, beyond which is triggered undesirable downstream effects that eventuate in loss of renal function. If this model parallels human CKD, clinicians may focus efforts on determining phosphate exposure in the proximal tubular lumen.

Identifiants

pubmed: 34396990
pii: e151858
doi: 10.1172/JCI151858
pmc: PMC8363275
doi:
pii:

Substances chimiques

Phosphates 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Comment

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL134373
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK091392
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK081423
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK079328
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK115703
Pays : United States

Commentaires et corrections

Type : CommentOn

Références

Kidney Int. 1996 Jun;49(6):1774-7
pubmed: 8743495
J Am Soc Nephrol. 2008 Feb;19(2):197-206
pubmed: 18199796
Circ Res. 2012 Aug 17;111(5):575-84
pubmed: 22753077
Nephrol Dial Transplant. 2000;15 Suppl 6:74-5
pubmed: 11143999
Am J Physiol. 1981 Jul;241(1):F85-93
pubmed: 7246778
Nephrol Dial Transplant. 2021 Jan 27;:
pubmed: 33502502
Am J Med. 1969 Jan;46(1):1-11
pubmed: 4952757
Am J Med. 1960 Jan;28:77-98
pubmed: 13804370
Nat Rev Nephrol. 2017 Apr;13(4):226-240
pubmed: 28218266
Kidney Int. 2021 Jan;99(1):208-217
pubmed: 32721446
JAMA. 2007 Nov 7;298(17):2038-47
pubmed: 17986697
J Biol Chem. 2003 Apr 11;278(15):13333-41
pubmed: 12556469
J Exp Med. 1935 Feb 28;61(3):319-34
pubmed: 19870361
J Clin Invest. 2021 Aug 16;131(16):
pubmed: 34185705

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH